Related Experiment Video
Updated: May 22, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus
Nigar Sekercioglu1, Chrysostomos Dimitriadis, Chrysoula Pipili
1The Home Peritoneal Dialysis Unit, Toronto General Hospital, University Health Network and University of Toronto, 200 Elizabeth Street, 8N-840, Toronto, ON, M5G 2C4, Canada.
Insights
Glycated hemoglobin (HbA1c) levels did not predict survival in diabetic peritoneal dialysis (PD) patients. Neither baseline nor time-averaged HbA1c values showed a significant correlation with patient or PD technique survival.
Area of Science:
- Nephrology
- Endocrinology
- Clinical Research
Background:
- Glycemic control is crucial for patients with diabetes mellitus.
- The optimal target for glycated hemoglobin (HbA1c) in peritoneal dialysis (PD) patients with diabetes remains undefined.
- Understanding glycemic control's impact on PD patient outcomes is essential.
Purpose of the Study:
- To evaluate the predictive value of predialysis and time-averaged HbA1c on survival in diabetic PD patients.
- To determine if specific HbA1c targets improve outcomes in this population.
Main Methods:
- Retrospective study of 91 diabetic PD patients from 2003-2008.
- Analysis of baseline and time-averaged follow-up HbA1c values.
- Assessment of correlation with patient and PD technique survival over a median follow-up of 30 months.
Main Results:
- No statistically significant correlation was found between baseline HbA1c and survival.
- Time-averaged HbA1c levels (categorized as <6.5%, 6.5-8%, and >8%) did not show significant differences in survival among groups.
- 40 out of 91 patients died during the follow-up period.
Conclusions:
- Neither baseline nor time-averaged HbA1c values significantly correlate with patient or PD technique survival.
- Current HbA1c targets may not be directly predictive of outcomes in diabetic PD patients.
- Further research may be needed to identify optimal glycemic management strategies for this cohort.
Purpose:
The optimal target for glycated hemoglobin (HbA1c) has not been well defined in peritoneal dialysis (PD) patients with diabetes mellitus.
Methods:
The objective of our study was to examine the predictive value of predialysis and time-averaged follow-up HbA1c values on technique and patient survival in diabetic PD patients treated in the Toronto General Hospital Home Peritoneal Dialysis Unit, between January 1, 2003 and December 31, 2008 with a median follow-up period of 30±23 months.
Results:
Ninety-one patients (mean age 64±13 years-old) were included in this retrospective study. Patients were followed between 3 and 91 months (mean duration 30±23 months). During this period, 40 patients died. We found no statistically significant correlation between baseline predialysis HbA1c values and technique and patient survival. Time-averaged follow-up HbA1c in increments<6.5%, 6.5-8%, and >8% showed no significant survival difference among groups.
Conclusions:
There was no significant correlation of baseline and time-averaged follow-up HbA1c values with patient and PD technique survival.
Related Concept Videos
Peritoneal Dialysis III: Nursing Management
Diabetic Nephropathy
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
